In line with this, our study identified a highly conserved CRE called BE5.2, which contained a polymorphism associated with mood disorders that reduced BP4 activity in all our primary neuronal cultures and abolished BP4 response to PKC activation by PMA treatment. This evidence concerns the gene PRRT2 and mood disorder.